CDI CORP : Executive Anna M. Seal Elected to CDI Corp. Board of Directors
09/24/2010| 03:45pm US/Eastern
PHILADELPHIA Sept. 24 /PRNewswire-FirstCall/ -- CDI Corp. (NYSE: CDI), a leading provider of engineering and information technology outsourcing solutions and professional staffing, has announced that Anna M. Seal has been elected to its Board of Directors and will serve on the Board's Audit Committee.
Ms. Seal is Senior Vice President and Chief Financial Officer of GlaxoSmithKline's (GSK) Global Manufacturing and Supply Division. She previously served as Senior Vice President and CFO of SmithKline Beecham Worldwide Supply Operations, Vice President and CFO of SmithKline Beecham Animal Health Division, and Chief Auditor and Vice President, Corporate Audits, of SmithKline Beecham.
"Anna's extensive expertise in financial management, her global business perspective, and her keen strategic insight will help CDI as we continue to expand our solutions capabilities to service our clients on a worldwide basis," said Walter Garrison, Chairman of the CDI Corp. Board of Directors. "On behalf of the entire Board of Directors, I am pleased to welcome Anna to CDI."
Ms. Seal is a C.P.A. who graduated with honors from Pennsylvania State University and completed the Executive Management Program at INSEAD University in Paris, France. She currently serves on the Board of Big Brothers Big Sisters. She has also served on the Board of the Please Touch Museum, Arrow International, the GSK Diversity Board and the GSK Charitable Contributions Board. Ms. Seal was named one of "25 Women CFO's to Watch" by CFO Magazine in June 2008.
Headquartered in Philadelphia, CDI Corp. (NYSE: CDI) is a leading provider of engineering and information technology outsourcing solutions and professional staffing. Its operating units include CDI Engineering Solutions, CDI IT Solutions, CDI AndersElite Limited and Management Recruiters International, Inc. Visit CDI at www.cdicorp.com.
SOURCE CDI Corp.